51-60 of 308 results

The Federal Court bores down into the 'experimental purposes' exemption to patent infringement
Insight 01 Sep 2022

The Patents Act 1990 (Cth) provides an exemption to patent infringement in relation to acts 'done for experimental purposes'. However, the exemption had not (until recently) been considered by any Australian court. More than a decade after the exemption was introduced, the Federal Court has provided ...

The Federal Court rules that bossy letters to Boss' customers are misleading but not threatening
Insight 01 Sep 2022

The long-awaited sequel to 1986's Top Gun, in which Tom Cruise reprises his role as US navy pilot Pete 'Maverick' Mitchell, has taken the global box office by storm. However, whether the studio behind the film had the necessary rights to make it is now the subject of a lawsuit. ...

Treasury Wine secures important court win in China to protect Penfolds brand
Insight 01 Sep 2022

A subsidiary of Treasury Wine Estates (TWE) has succeeded in a claim against a trader operating in China (East Bright Sunshine) to protect the Penfolds brand. This will be a welcome result for brands looking to enforce their rights against infringers in China. Brand owners should consider their trade mark protection and enforcement strategies in China. ...

The Full Federal Court has its say on authorisation of copyright infringement
Insight 01 Sep 2022

The Full Federal Court has delivered its judgment in Campaigntrack Pty Ltd v Real Estate Tool Box Pty Ltd and, although the court ultimately allowed Campaigntrack's appeal, was divided on authorisation of copyright infringement. We analyse this interesting decision and its effects. ...

Australia rules on patents for computer-implemented inventions
Insight 29 Aug 2022

The High Court of Australia has grappled with the question of when a computer-implemented invention is patentable. Unfortunately, for technology owners and implementers in this space, the bench was split evenly. By a technicality, the case (Aristocrat Technologies Australia Pty Ltd v Commissioner of Patents [2022] HCA 29) was decided against the patentee. In this Insight we unpack the two High Court opinions and how these approaches compare to recent case law and Patent Office practice. ...

Priority window closes soon for .au direct domain names
Insight 25 Aug 2022

Further to our last update, the window for existing holders of .au domain names (eg .com.au or .net.au) to claim priority status to register matching .au direct names (eg 'allens.au' instead of 'allens.com.au') closes on 20 September 2022. ...

Food and beverage law bulletin
Insight 08 Aug 2022

Latest insights on what's been happening in food and beverage law; M&A trends: ESG, innovative agriculture, craft beer and plant-based alternatives; an update on trade mark law in the food and beverage sector; and other key developments in 2022. ...

Software-based medical devices: key regulatory requirements, IP considerations and data privacy implications
Insight 29 Jul 2022

Software is increasingly being used as a medical device and in medical devices. It is crucial that businesses understand the regulations that can apply to software-based medical devices, the IP considerations if they wish to protect such devices and the privacy-related risks associated with the collection and use of data from such devices. This Insight explores each of these issues in turn. ...

M&A trends in the food and beverage sector: ESG, innovative agriculture, craft beer and plant-based alternatives
Insight 28 Jul 2022

With ESG front of mind, we take a deep dive into some of the M&A trends within the food and beverage sector and outline some key factors that we expect to attract global investment in the years to come. ...

The mRNA rush
Insight 30 Jun 2022

There is great potential for mRNA technology to revolutionise future vaccines, and treatment of various conditions such as rare genetic disorders, other infectious diseases and even cancer. The enthusiasm for the technology – or the 'mRNA rush' – is reflected by a spike in patent filings over the past five years, and the growing patent portfolios of key mRNA pioneers and market players. ...

Refine